How should a distributor qualify a shortlisted nebulizer manufacturer?
Reconcile legal identity and site, quality-system scope, process ownership, supplier controls, production and release records, change control, exact-model evidence and a dated decision with open actions. Remote evidence plans the audit; it does not replace it.
FDA QMSR and MDSAP purchasing-process guidance plus model-level records.
This checklist does not certify Mericonn or rank suppliers.
Qualifying a nebulizer manufacturer means checking whether its legal identity, quality-system scope, process ownership, supplier controls and product evidence fit the risk of the proposed project. A polished factory video, marketplace badge or certificate logo can start a conversation, but none is a complete qualification decision.
A seven-part supplier evidence pack
| Qualification area | Remote evidence to request | What may still require direct verification |
|---|---|---|
| Legal identity and site | Business identity, address, legal manufacturer and site relationship | Actual operations at the stated facility and any outsourced sites |
| Quality-management system | Current certificate, holder, site, scope, issuer and validity | Whether daily practices and records conform to the documented system |
| Process ownership | Process map, in-house and outsourced steps, key equipment and responsible functions | Equipment condition, capacity, operator practice and process controls |
| Supplier controls | Risk-based selection criteria, approved-supplier logic and incoming acceptance approach | Representative records, current supplier performance and escalation effectiveness |
| Production and release | Released instructions, in-process and final acceptance examples, lot or build traceability | Execution on the floor and completeness of records for the chosen model |
| Change and nonconformity control | Revision workflow, change-notification terms, deviation and CAPA examples | Timely implementation, effectiveness checks and project-specific notification rights |
| Product and market evidence | Exact-model specification, labeling, test reports and regulatory records | Current commercial configuration and destination-market compliance |
1. Resolve the legal manufacturer and physical site
Match the legal name and address across quotations, labels, quality certificates and product records. Ask whether development, molding, critical component production, assembly, testing, warehousing or release occurs at another site. A trading address and a manufacturing address can serve different functions; the relationship should be explicit.
2. Read the quality certificate beyond its logo
Check the holder, covered site, scope, issuing body, certificate number, issue and expiry dates, and any annex. A certificate describes a management-system scope; it does not automatically establish product clearance, exact-model performance or compliance in every destination market. Mericonn’s public profile states ISO 9001 and ISO 13485 certification, but current certificates and exact scope should still be requested before a commercial decision.
3. Map in-house and outsourced processes
Mericonn’s official profile states in-house injection molding, mesh nebulizer plate production, product assembly and a professional quality testing center. These statements are useful starting points, not a completed audit. Ask for current dated facility photographs, a live tour where appropriate, equipment and calibration lists, process-flow ownership and representative controlled records.
4. Examine risk-based supplier controls
FDA’s current Quality Management System Regulation incorporates ISO 13485:2016. FDA’s MDSAP purchasing-process model expects supplier selection, monitoring and re-evaluation to be based on defined criteria and risk, with purchasing requirements and acceptance evidence documented. For a buyer, the practical question is how the manufacturer controls components and services that can affect finished-device quality.
5. Connect the approved sample to production release
Record the approved reference configuration: model, medicine cup, electronics, power source, software where relevant, accessories, labeling, instructions and packaging. Ask which changes trigger review, how deviations are approved and what final-release evidence is retained. Do not assume a positive sample result alone guarantees future production equivalence.
6. Match every product claim to exact-model evidence
Keep the specification, performance method, regulatory record and commercial configuration together. For Mericonn’s FDA-cleared mesh nebulizers, K254171 names UN204, UN205, UN209 and UN210; it is not blanket evidence for every nebulizer. Use the pre-sample document gate and certificate-scope guide to structure the file review.
7. Record a decision with conditions and owners
A qualification record should say what was accepted, what remains open, who owns each action and when re-evaluation is due. Useful dispositions include qualified, conditionally qualified, pending evidence and not qualified. Supplier qualification is not permanent; complaints, nonconformities, changes and delivery performance can trigger re-review.
Red flags that deserve escalation
- The legal name, site or certificate holder changes between documents without explanation.
- Factory images have no date or cannot be tied to the stated site.
- Critical outsourced processes are presented as in-house or left unidentified.
- Model-specific test data is replaced by a catalogue number or a generic badge.
- Supplier changes, nonconformities or production revisions have no documented review path.
- Audit access or representative records are refused without a reasonable confidentiality route.
Review Mericonn’s stated manufacturing capabilities and public evidence boundaries. To plan a model-specific review, use the quality-document inquiry.